Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Guggenheim ...

Revumenib is now the sole targeted therapy recommended by the National Comprehensive Cancer Network for KMT2A-rearranged acute leukemia, which opens a path for payers, said Ivo Abraham, PhD, RN, of ...